9342 8530 Qubec Stock Revenue
9342 8530 Qubec fundamentals help investors to digest information that contributes to 9342-8530 Qubec's financial success or failures. It also enables traders to predict the movement of 9342-8530 Stock. The fundamental analysis module provides a way to measure 9342-8530 Qubec's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 9342-8530 Qubec stock.
9342-8530 |
9342 8530 Qubec Company Revenue Analysis
9342-8530 Qubec's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current 9342-8530 Qubec Revenue | 515.37 K |
Most of 9342-8530 Qubec's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 9342 8530 Qubec is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, 9342 8530 Qubec reported 515.37 K of revenue. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is notably lower than that of the firm.
9342-8530 Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 9342-8530 Qubec's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 9342-8530 Qubec could also be used in its relative valuation, which is a method of valuing 9342-8530 Qubec by comparing valuation metrics of similar companies.9342 8530 is currently under evaluation in revenue category among its peers.
9342-8530 Fundamentals
| Return On Equity | 1.28 | |||
| Return On Asset | 1.34 | |||
| Profit Margin | 0.41 % | |||
| Operating Margin | 0.77 % | |||
| Current Valuation | (392.06 K) | |||
| Shares Outstanding | 43.04 M | |||
| Price To Sales | 0 X | |||
| Revenue | 515.37 K | |||
| Gross Profit | 117.96 K | |||
| EBITDA | 5.46 M | |||
| Net Income | (3.6 M) | |||
| Cash And Equivalents | 392.49 K | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 3.74 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.17 M) | |||
| Earnings Per Share | 0.05 X | |||
| Beta | 0.98 | |||
| Market Capitalization | 43 | |||
| Total Asset | 1.79 M | |||
| Retained Earnings | (74.97 M) | |||
| Working Capital | 465 K | |||
| Current Asset | 741 K | |||
| Current Liabilities | 276 K | |||
| Z Score | -47.5 | |||
| Net Asset | 1.79 M |
About 9342-8530 Qubec Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 9342 8530 Qubec's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 9342-8530 Qubec using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 9342 8530 Qubec based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in 9342-8530 Stock
If you are still planning to invest in 9342 8530 Qubec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 9342-8530 Qubec's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |